You have 9 free searches left this month | for more free features.

baf312

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatic Impairment Trial in Balatonfured, Budapest, Moscow (BAF312)

Completed
  • Hepatic Impairment
  • BAF312
  • Balatonfured, Hungary
  • +2 more
Dec 6, 2020

Polymyositis Trial in Worldwide (Placebo, BAF312)

Terminated
  • Polymyositis
  • Placebo
  • BAF312
  • Phoenix, Arizona
  • +7 more
Dec 9, 2020

Renal Impairment Trial in Orlando, Bucuresti (BAF312)

Completed
  • Renal Impairment
  • BAF312
  • Orlando, Florida
  • +1 more
Dec 6, 2020

Active Dermatomyositis Trial in Czechia, Japan, United States (BAF312, Placebo)

Terminated
  • Active Dermatomyositis
  • BAF312
  • Placebo
  • Phoenix, Arizona
  • +8 more
Dec 9, 2020

Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))

Active, not recruiting
  • Secondary Progressive Multiple Sclerosis
  • BAF312
  • Baseline disease modifying therapies (DMTs)
  • Mittweida, Sachsen, Germany
  • +9 more
Aug 9, 2022

Polymyositis, Dermatomyositis Trial in Worldwide (BAF312, Placebo)

Terminated
  • Polymyositis
  • Dermatomyositis
  • BAF312
  • Placebo
  • Boston, Massachusetts
  • +5 more
Apr 3, 2019

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (BAF312, Placebo)

Completed
  • Relapsing-remitting Multiple Sclerosis
  • BAF312
  • Placebo
  • Cullman, Alabama
  • +71 more
Dec 26, 2019

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (BAF312)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • BAF312
  • Miami, Florida
  • +45 more
Feb 27, 2018